Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/8155391

Download in:

View as

General Info

PMID
8155391